Idorsia Ltd. (IDRSF)
5.38
-0.02
(-0.37%)
USD |
OTCM |
Oct 02, 16:00
Idorsia Max Drawdown (5Y) : 97.99% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 97.99% |
| August 31, 2026 | 97.99% |
| July 31, 2026 | 97.99% |
| June 30, 2026 | 97.99% |
| May 31, 2026 | 97.99% |
| April 30, 2026 | 97.99% |
| March 31, 2026 | 97.99% |
| February 28, 2026 | 97.99% |
| January 31, 2026 | 97.99% |
| December 31, 2025 | 97.99% |
| November 30, 2025 | 97.99% |
| October 31, 2025 | 97.99% |
| September 30, 2025 | 97.99% |
| August 31, 2025 | 97.99% |
| July 31, 2025 | 97.99% |
| June 30, 2025 | 97.99% |
| May 31, 2025 | 97.99% |
| April 30, 2025 | 97.99% |
| March 31, 2025 | 97.99% |
| February 28, 2025 | 97.99% |
| January 31, 2025 | 97.99% |
| December 31, 2024 | 97.99% |
| November 30, 2024 | 97.67% |
| October 31, 2024 | 96.83% |
| September 30, 2024 | 95.97% |
| Date | Value |
|---|---|
| August 31, 2024 | 95.97% |
| July 31, 2024 | 95.97% |
| June 30, 2024 | 95.97% |
| May 31, 2024 | 95.97% |
| April 30, 2024 | 95.97% |
| March 31, 2024 | 95.97% |
| February 29, 2024 | 95.97% |
| January 31, 2024 | 95.97% |
| December 31, 2023 | 95.25% |
| November 30, 2023 | 95.25% |
| October 31, 2023 | 95.25% |
| September 30, 2023 | 92.23% |
| August 31, 2023 | 84.32% |
| July 31, 2023 | 79.14% |
| June 30, 2023 | 78.42% |
| May 31, 2023 | 75.54% |
| April 30, 2023 | 72.66% |
| March 31, 2023 | 68.20% |
| February 28, 2023 | 66.56% |
| January 31, 2023 | 66.56% |
| December 31, 2022 | 66.56% |
| November 30, 2022 | 66.56% |
| October 31, 2022 | 66.56% |
| September 30, 2022 | 66.56% |
| August 31, 2022 | 66.56% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Basilea Pharmaceutica AG | 55.70% |
| Santhera Pharmaceuticals Holding AG | 98.31% |
| BeOne Medicines Ltd. | 69.96% |
| AC Immune SA | 89.55% |
| CRISPR Therapeutics AG | 85.11% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -47.31 |
| Beta (5Y) | 1.739 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 92.02% |
| Historical Sharpe Ratio (5Y) | -0.3251 |
| Historical Sortino (5Y) | -0.6155 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.27% |